首页 | 本学科首页   官方微博 | 高级检索  
     

中国非手术治疗食管癌研究进展
引用本文:孙苏平,杨鸿鹏,黎功. 中国非手术治疗食管癌研究进展[J]. 癌症进展, 2008, 6(1): 30-35
作者姓名:孙苏平  杨鸿鹏  黎功
作者单位:南京医科大学附属常州第二人民医院,常州,213003;徐州市肿瘤医院,徐州,221005;武警部队总医院肿瘤中心,北京,100039
基金项目:徐州市科技局资助项目,项目号:X2003024
摘    要:
食管癌常规放射治疗的长期生存率为4.3%~16.4%,80%以上的治疗失败是由于局部病灶未控或复发。非常规分割方法将食管癌放射治疗的5年生存率提高了15%以上,同期放化疗结合治疗食管癌也显示出其优势。治疗方案的个体化可进一步增加疗效,降低并发症,提高生活质量。生物学方法可能为非手术治疗食管癌个体化治疗方案的选择提供思路。

关 键 词:食管癌  放射治疗  化学治疗

Progress in non-surgical treatment of esophageal carcinoma
Sun Suping,Yang Hongpeng,Li Gong. Progress in non-surgical treatment of esophageal carcinoma[J]. Oncology Progress, 2008, 6(1): 30-35
Authors:Sun Suping  Yang Hongpeng  Li Gong
Affiliation:Sun Suping, Yang Hongpeng, Li Gong(1 Nanjing Medical University, Changzhou Second Hospital, Changzhou 213003, China ; 2 Xuzhou Cancer Hospital, Xuzhou 221005, China ;3Oncology Center, General Hospital of the People's Armed Police Forces of Beijing, Beijing 100039, China)
Abstract:
The long-term survival rate of esophageal carcinoma is 4.3%-16.4% after conventional- ly fractionated radiotherapy(CR),which mainly results from local regional treatment failure and regional recurrence.Unconventional fractionation radiotherapy has increased the 5-year survival rate of esophageal carcinoma by 15%,while concurrent chemoradiotherapy also provides significant therapeutic benefits. Individualized treatment scheme may achieve more therapeutic benefits,reduce complications,and im- prove quality of life.Biological method may facilitate the choice of treatment scheme.
Keywords:esophageal carcinoma  radiothearpy  chemothearpy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号